Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06957691
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:16.049957+00:00
Published At
2026-03-09T00:00:00+00:00
Record Updated At
2026-03-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Prostate Cancer", "Prostate Cancer (Adenocarcinoma)", "Prostate Cancer Metastatic Disease", "Prostate Cancer Recurrent", "Prostate Carcinoma", "Prostate Neoplasm", "Prostate Adenocarcinoma", "Prostate Cancer With Bone Metastasis", "Vasomotor Disturbance", "Vasomotor Symptoms", "Vasomotor Symptoms (VMS)", "Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men", "Vasomotor Symptoms; Hot Flashes", "Androgen Deprivation Therapy", "Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma", "Androgen-deprivation Therapy", "Hot Flashes", "Hot Flushes", "Hot Flushes and/or Sweats"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-09"
protocolSection.identificationModule.nctId
"NCT06957691"
protocolSection.identificationModule.officialTitle
"Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (Adenocarcinoma) (protocolSection.conditionsModule.conditions)
  • Prostate Cancer Metastatic Disease (protocolSection.conditionsModule.conditions)
  • Prostate Cancer Recurrent (protocolSection.conditionsModule.conditions)
  • Prostate Carcinoma (protocolSection.conditionsModule.conditions)
  • Prostate Neoplasm (protocolSection.conditionsModule.conditions)
  • Prostate Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Prostate Cancer With Bone Metastasis (protocolSection.conditionsModule.conditions)
  • Vasomotor Disturbance (protocolSection.conditionsModule.conditions)
  • Vasomotor Symptoms (protocolSection.conditionsModule.conditions)
  • Vasomotor Symptoms (VMS) (protocolSection.conditionsModule.conditions)
  • Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men (protocolSection.conditionsModule.conditions)
  • Vasomotor Symptoms; Hot Flashes (protocolSection.conditionsModule.conditions)
  • Androgen Deprivation Therapy (protocolSection.conditionsModule.conditions)
  • Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma (protocolSection.conditionsModule.conditions)
  • Androgen-deprivation Therapy (protocolSection.conditionsModule.conditions)
  • Hot Flashes (protocolSection.conditionsModule.conditions)
  • Hot Flushes (protocolSection.conditionsModule.conditions)
  • Hot Flushes and/or Sweats (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.